Literature DB >> 3341139

The efficacy of PlA1-negative platelet transfusion therapy in posttransfusion purpura.

S M Lippman, G E Lizak, S K Foung, F C Grumet.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1988        PMID： 3341139      PMCID： PMC1026031     

Source DB:  PubMed          Journal:  West J Med        ISSN： 0093-0415


× No keyword cloud information.
  12 in total

1.  Correction of poor platelet transfusion responses with leukocyte-poor HL-A-matched platelet concentrates.

Authors:  R H Herzig; G P Herzig; M I Bull; J A Decter; H P Lohrmann; F G Stout; R A Yankee; R G Graw
Journal:  Blood       Date:  1975-11       Impact factor: 22.113

2.  IMMUNOREACTIONS INVOLVING PLATELETS. V. POST-TRANSFUSION PURPURA DUE TO A COMPLEMENT-FIXING ANTIBODY AGAINST A GENETICALLY CONTROLLED PLATELET ANTIGEN. A PROPOSED MECHANISM FOR THROMBOCYTOPENIA AND ITS RELEVANCE IN "AUTOIMMUNITY".

Authors:  N R Shulman; R H Aster; A Leitner; M C Hiller
Journal:  J Clin Invest       Date:  1961-09       Impact factor: 14.808

3.  [Post-transfusion purpura. Apropos of a case treated by plasma exchange and transfusion of P1 A1 negative platelets].

Authors:  G Le Roux; J L Pourriat; C Lapandry; J P Aufeuvre; A Le Floch; J Baudelot; P Lortholary
Journal:  Rev Fr Transfus Immunohematol       Date:  1981-04

Review 4.  Platelet-specific antigen systems and their detection.

Authors:  W V Miller; J A Harmon
Journal:  Prog Clin Biol Res       Date:  1984

Review 5.  Clinical significance of platelet-specific antigens and antibodies.

Authors:  R H Aster
Journal:  Prog Clin Biol Res       Date:  1984

6.  Posttransfusion purpura: therapeutic failure of PlAl-negative platelet transfusion.

Authors:  J B Gerstner; M J Smith; K D Davis; P L Cimo; R H Aster
Journal:  Am J Hematol       Date:  1979       Impact factor: 10.047

7.  Platelet transfusion therapy. Optimal donor selection with a combination of lymphocytotoxicity and platelet fluorescence tests.

Authors:  A Brand; A van Leeuwen; J G Eernisse; J J van Rood
Journal:  Blood       Date:  1978-05       Impact factor: 22.113

8.  High-dose intravenous immunoglobulin for post-transfusion purpura.

Authors:  T K Glud; S Rosthøj; M K Jensen; B Laursen; N Grunnet; C Jersild
Journal:  Scand J Haematol       Date:  1983-11

9.  Detection of platelet antibodies by anti-kappa light chain facilitation of C-FDA (KC-FDA) thrombocytotoxicity.

Authors:  G E Lizak; F C Grumet
Journal:  Hum Immunol       Date:  1983-12       Impact factor: 2.850

10.  Post-transfusion purpura: an enigma of alloimmunization.

Authors:  P Lau; C M Sholtis; R H Aster
Journal:  Am J Hematol       Date:  1980       Impact factor: 10.047
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.